KIF23 is a potential biomarker of diffuse large B cell lymphoma
Yuqi Gong, PhD, Lingna Zhou, MD, Liya Ding, MD, Jing Zhao, MD, Zhe Wang, PhD, Guoping Ren, PhD, Jing Zhang, PhD, Zhengrong Mao, PhD, Ren Zhou, PhD
Published in Medicine (Baltimore) (01.06.2022)
Published in Medicine (Baltimore) (01.06.2022)
Get full text
Journal Article